GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
5IDL | 5IDL | Crystal structure of the germline-targeting HIV-1 gp120 engineered outer domain, eOD-GT8 | |
5IES | 5IES | Crystal structure of VRC01c-HuGL2 Fab from an HIV-1 naive donor in complex with with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.16 A | |
5IF0 | 5IF0 | Crystal structure of VRC01c-HuGL2 Fab from an HIV-1 naive donor in complex with with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.44 A | |
5IGX | 5IGX | Crystal structure of NIH45-46 Fab germline precursor in complex with 426c.TM1deltaV1-3 gp120 | |
5IQZ | 5IQZ | Crystal structure of N-terminal domain of Human SIRT7 | |
5IR1 | 5IR1 | Cetuximab Fab in complex with 3-bromophenylalanine meditope variant | |
5IUE | 5IUE | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5IWL | 5IWL | CD47-diabody complex | 5F9 diabody, Leukocyte surface antigen CD47 |
5J3H | 5J3H | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
5JMN | 5JMN | Fusidic acid bound AcrB | |
5JMO | 5JMO | X-ray structure of furin in complex with the inhibitory antibody Nb14 | |
5JOP | 5JOP | Crystal structure of anti-glycan antibody Fab14.22 in complex with Streptococcus pneumoniae serotype 14 tetrasaccharide at 1.75 A | |
5JQ3 | 5JQ3 | Crystal structure of Ebola glycoprotein | |
5JQ3 | 5JQ3 | Crystal structure of Ebola glycoprotein | |
5JQ7 | 5JQ7 | Crystal structure of Ebola glycoprotein in complex with toremifene | |
5JQ7 | 5JQ7 | Crystal structure of Ebola glycoprotein in complex with toremifene | |
5JQB | 5JQB | Crystal structure of Ebola glycoprotein in complex with ibuprofen | |
5JQB | 5JQB | Crystal structure of Ebola glycoprotein in complex with ibuprofen | |
5JS9 | 5JS9 | Uncleaved prefusion optimized gp140 trimer with an engineered 8-residue HR1 turn bound to broadly neutralizing antibodies 8ANC195 and PGT128 | |
5JSA | 5JSA | Uncleaved prefusion optimized gp140 trimer with an engineered 10-residue HR1 turn bound to broadly neutralizing antibodies 8ANC195 and PGT128 | |
5JSD | 5JSD | Crystal structure of phiAB6 tailspike in complex with five-repeated oligosaccharides of Acinetobacter baumannii surface polysaccharide | |
5JSE | 5JSE | Crystal structure of phiAB6 tailspike in complex with three-repeated oligosaccharides of Acinetobacter baumannii surface polysaccharide | |
5JU9 | 5JU9 | Structure of a beta-1,4-mannanase, SsGH134, in complex with Man3. | |
5JUG | 5JUG | Structure of an inactive (E45Q) variant of a beta-1,4-mannanase, SsGH134, in complex with Man5 | |
5JW3 | 5JW3 | Structure of MEDI8852 Fab Fragment in Complex with H7 HA | |
5JW4 | 5JW4 | Structure of MEDI8852 Fab Fragment in Complex with H5 HA | |
5K6M | 5K6M | Structure of a GH3 b-glIcosidase from cow rumen metagenome in complex with glucose | |
5K6N | 5K6N | Structure of a GH3 b-glicosidase from cow rumen metagenome in complexed with xylose | |
5K6O | 5K6O | Structure of a GH3 b-glucosidase from cow rumen metagenome in complex with galactose | |
5K9K | 5K9K | Crystal structure of multidonor HV6-1-class broadly neutralizing Influenza A antibody 56.a.09 in complex with Hemagglutinin Hong Kong 1968. | |
5K9O | 5K9O | Crystal structure of multidonor HV1-18+HD3-9 class broadly neutralizing Influenza A antibody 31.b.09 in complex with Hemagglutinin H1 A/California/04/2009 | |
5K9Q | 5K9Q | Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.a.26 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin | Hemagglutinin, hemagglutinin HA2, 16.a.26 Heavy chain, 16.a.26 Light chain |
5KAN | 5KAN | Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.g.07 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin | |
5KAQ | 5KAQ | Crystal structure of broadly neutralizing Influenza A antibody 31.a.83 in complex with Hemagglutinin Hong Kong 1968. | Hemagglutinin, ANTIBODY 31.A.83 FAB HEAVY CHAIN, ANTIBODY 31.A.83 FAB LIGHT CHAIN |
5KBN | 5KBN | The crystal structure of fluoride channel Fluc Ec2 F80I Mutant | |
5KDS | 5KDS | ZmpB metallopeptidase in complex with an O-glycopeptide (a2,6-sialylated core-3 pentapeptide). | |
5KEL | 5KEL | EBOV GP in complex with variable Fab domains of IgGs c2G4 and c13C6 | Ebola surface glycoprotein, GP1, Ebola surface glycoprotein, GP2, c2G4 variable Fab domain heavy chain, c2G4 variable Fab domain light chain, c13C6 variable Fab domain heavy chain, c13C6 variable Fab domain light chain |
5KEN | 5KEN | EBOV GP in complex with variable Fab domains of IgGs c4G7 and c13C6 | Ebola surface glycoprotein, GP1, Ebola surface glycoprotein, GP2, c4G7 variable Fab domain heavy chain, c4G7 variable Fab domain light chain, c13C6 variable Fab domain light chain, c13C6 variable Fab domain heavy chain |
5KJR | 5KJR | Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1. | |
5KNM | 5KNM | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KOM | 5KOM | The crystal structure of fluoride channel Fluc Ec2 F83I Mutant | |
5KOV | 5KOV | Crystal structure of the human astrovirus 2 capsid protein spike in complex with a single chain variable fragment of an astrovirus neutralizing antibody at 3.24-A resolution | |
5KQV | 5KQV | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
5KS9 | 5KS9 | Bel502-DQ8-glia-alpha1 complex | |
5KS9 | 5KS9 | Bel502-DQ8-glia-alpha1 complex | |
5KSA | 5KSA | Bel602-DQ8.5-glia-gamma1 complex | HLA class II histocompatibility antigen, DQ alpha 1 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Bel602 alpha TRAV20*01, Bel602 beta TRBV9*01, DQ8.5-glia-gamma1 peptide |
5KSA | 5KSA | Bel602-DQ8.5-glia-gamma1 complex | HLA class II histocompatibility antigen, DQ alpha 1 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Bel602 alpha TRAV20*01, Bel602 beta TRBV9*01, DQ8.5-glia-gamma1 peptide |
5KSB | 5KSB | T15-DQ8.5-glia-gamma1 complex | HLA class II histocompatibility antigen, DQ alpha 1 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, T15 TCR alpha TRAV20*02, T15 TCR beta TRBV9*01, DQ8.5-glia-gamma1 peptide |
5KSB | 5KSB | T15-DQ8.5-glia-gamma1 complex | HLA class II histocompatibility antigen, DQ alpha 1 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, T15 TCR alpha TRAV20*02, T15 TCR beta TRBV9*01, DQ8.5-glia-gamma1 peptide |
5KUY | 5KUY | Influenza hemagglutinin H3 A/Hong Kong/1/1968 in complex with designed inhibitor protein HSB.2A |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024